Salud financiera de hoja de balance de Dermapharm Holding
Salud financiera controles de criterios 3/6
Dermapharm Holding tiene un patrimonio de accionistas total de €545.0M y una deuda total de €1.1B, lo que sitúa su ratio deuda-patrimonio en 194.9%. Sus activos y pasivos totales son €2.2B y €1.6B respectivamente. El BAIT de Dermapharm Holding es de €193.2M, por lo que su ratio de cobertura de intereses es de 3.7. Tiene efectivo e inversiones a corto plazo que ascienden a €159.5M.
Información clave
194.9%
Ratio deuda-patrimonio
€1.06b
Deuda
Ratio de cobertura de intereses | 3.7x |
Efectivo | €159.54m |
Patrimonio | €545.05m |
Total pasivo | €1.62b |
Activos totales | €2.16b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Recent updates
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (€630.5M) de DMP superan a sus pasivos a corto plazo (€394.5M).
Pasivo a largo plazo: Los activos a corto plazo (€630.5M) de DMP no cubren sus pasivos a largo plazo (€1.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de DMP (165.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de DMP ha crecido de 118.7% a 194.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de DMP está bien cubierta por el flujo de caja operativo (20.7%).
Cobertura de intereses: Los pagos de intereses de la deuda de DMP están bien cubiertos por el BAIT (3.7x cobertura).